Product development clinical trial and commercialisation of revolutionary bedside sleep device SleepCogni.

革命性床边睡眠设备 SleepCogni 的产品开发、临床试验和商业化。

• 批准号: 103595
• 金额: $ 41.29万
• 依托单位: BRAINTRAIN2020 LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2017
• 资助国家: 英国
• 起止时间: 2017 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=103595
• 关键词: Product; development; clinical; trial; commercialisation

Trouble to fall asleep or waking up in the middle of the night is a problem 1 in 3 around the world face. A lack of sleep leads to unhappiness, reduces performance, increases the risk of accidents and poses severe hazards to health, including cardiovascular disease and cancer. Current treatments for sleep issues do not work or are too costly, and the most frequent treatment, the sleeping pill, is highly addictive and does not provide a long-term solution. We have now developed a credible and innovative solution to the global sleep problem: SleepCogni, the bedside medical device that helps you sleep; integrating the latest scientific insights into sleep. Amongst its many features it provides a technological embedding of a treatment known to improve outcomes for patients with sleep disorders: Cognitive Behavioural Therapy. We now seek to bring this product to market to help the world sleep. To validate SleepCogni’s measurements and user experience we want to first test it in a laboratory sleep setting, before moving on to a placebo-controlled trial to confirm the effectiveness of SleepCogni to improve sleep.

难以入睡或半夜醒来是世界上三分之一的人面临的问题。睡眠不足会导致不快乐，降低工作表现，增加事故风险，并对健康造成严重危害，包括心血管疾病和癌症。目前针对睡眠问题的治疗方法要么无效，要么过于昂贵，而最常用的治疗方法——安眠药——极易上瘾，而且不能提供长期解决方案。我们现在已经为全球睡眠问题开发了一种可靠而创新的解决方案：SleepCogni，一种帮助你睡眠的床边医疗设备；将最新的科学见解融入睡眠。在它的众多功能中，它提供了一种技术嵌入的治疗方法，已知可以改善睡眠障碍患者的预后：认知行为疗法。我们现在寻求将这款产品推向市场，以帮助世界睡眠。为了验证SleepCogni的测量结果和用户体验，我们想先在实验室睡眠环境中进行测试，然后再进行安慰剂对照试验，以确认SleepCogni改善睡眠的有效性。